Gabapentin (Neurontin) and risk of abuse and dependence: new scheduling requirements from 1 April 2019 (UK)

As of 1 April 2019 in the UK, gabapentin is controlled under the Misuse of Drugs Act 1971 as a Class C substance and scheduled under the Misuse of Drugs Regulations 2001 as Schedule 3. Patients should be evaluated carefully for a history of drug abuse before prescribing gabapentin and patients should be observed for development of signs of abuse and dependence.

Gabapentin enacarbil is a prodrug of gabapentin.